Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Activision Completes Buyback Of Shares From Vivendi

RELATED NEWS
Trade ATVI now with 

Video game publisher Activision Blizzard, Inc. (ATVI: Quote) Friday said it completed the purchase of about 429 million company shares and certain tax attributes from French media giant Vivendi SA (VIVEF.PK, VIV.L), for around $5.83 billion, or $13.60 per share in cash.

In a separate simultaneous deal, ASAC II LP, an investment vehicle led by Activision Blizzard CEO Bobby Kotick and Chairman Brian Kelly, also completed its purchase of about 172 million company shares from Vivendi for around $2.34 billion in cash, or $13.60 per share.

With the closing of the deal, ASAC II LP now owns about 24.7 percent of the company. Vivendi has retained 83 million shares, an approximate 12 percent stake.

Activision Blizzard funded the acquisition with the combination of $1.2 billion of cash on hand and recently issued debt.

Click here to receive FREE breaking news email alerts for Activision Blizzard and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Stocks came under pressure in early trading on Friday and remained firmly in the red throughout the remainder of the trading session. With the losses on the day, the S&P 500 pulled back well off yesterday's record closing high. President Barack Obama is meeting with presidents from Central American nations on Friday as the U.S. struggles to deal with a surge of unaccompanied children across the southern border. Despite calls from some leading conservatives, the results of a new CNN/ORC International poll released Friday showed that a vast majority of Americans do not believe that President Barack Obama should be impeached and removed from office.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.